Literature DB >> 2439348

Cyclosporin depolarizes human lymphocytes: earliest observed effect on cell metabolism.

S Damjanovich, A Aszalós, S A Mulhern, J Szöllösi, M Balázs, L Trón, M J Fulwyler.   

Abstract

Cyclosporin A (CsA) produced dose-dependent membrane depolarization of human peripheral blood lymphocytes. The phenomenon was investigated applying the membrane potential probe dihexyloxacarbocyanine iodide in a flow cytometer in combination with ionophores, hormones and monoclonal antibodies binding to different subclasses of lymphocytes and the anti-interleukin 2 receptor antibody. Human interferon-gamma abolished the depolarizing effect of cyclosporin on lymphocytes. Interleukin 2 caused depolarization and also enhanced the effect of CsA. OKT4 and OKT8 monoclonal antibodies slightly hindered depolarization by CsA while OKT3, OKT11 and OKIa1 antibodies had no such effect. Valinomycin decreased CsA's effect on the membrane potential while the ionophore A-23187 and ionomycin caused depolarizations that were additive with CsA's. CsA treatment released the isotope from 42K-loaded human lymphocytes in a dose-dependent fashion. CsA addition increased intracellular calcium content. CsA decreased the motional freedom of a spin probe in the membrane, but did not hinder the binding of fluoresceinated antibodies to the cell surface. These results suggest immediate alteration in membrane structure upon CsA treatment, causing potassium leakage and calcium ion uptake. These are the earliest detected effects of CsA on cells so far.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439348     DOI: 10.1002/eji.1830170605

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Inhibitory actions of HERG currents by the immunosuppressant drug cyclosporin a.

Authors:  Seung Ho Lee; Sang June Hahn; Gyesik Min; Jimok Kim; Su-Hyun Jo; Han Choe; Bok Hee Choi
Journal:  Korean J Physiol Pharmacol       Date:  2011-10-31       Impact factor: 2.016

2.  Modulation of Multidrug Resistance in Cancer by Immunosuppresive Agents. Preclinical Studies.

Authors:  Adorján Aszalos
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

3.  Augmentative inhibition of lymphocyte proliferation by cyclosporin A combined with the riminophenazine compounds clofazimine and B669.

Authors:  Y Prinsloo; C E van Rensburg; R van der Walt; R Anderson
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

4.  Interaction of the B subunit of cholera toxin with endogenous ganglioside GM1 causes changes in membrane potential of rat thymocytes.

Authors:  S A Mulhern; P H Fishman; S Spiegel
Journal:  J Membr Biol       Date:  1989-07       Impact factor: 1.843

5.  Molecular basis for the immunosuppressive action of stearic acid on T cells.

Authors:  P W Tebbey; T M Buttke
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

6.  Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action?

Authors:  G Fricker; A Fahr
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.